Attached files

file filename
EX-10.2D - EXHIBIT 10.2D - Regen BioPharma Incex10_2d.htm
EX-10.1E - EXHIBIT 10.1E - Regen BioPharma Incex10_1e.htm
10-K - FORM 10-K - Regen BioPharma Incrgbp093017form10k.htm
EX-32.2 - EXHIBIT 32.2 - Regen BioPharma Incex32_2.htm
EX-32.1 - EXHIBIT 32.1 - Regen BioPharma Incex32_1.htm
EX-31.2 - EXHIBIT 31.2 - Regen BioPharma Incex31_2.htm
EX-31.1 - EXHIBIT 31.1 - Regen BioPharma Incex31_1.htm
EX-10.21D - EXHIBIT 10.21D - Regen BioPharma Incex10_21d.htm
EX-10.20D - EXHIBIT 10.20D - Regen BioPharma Incex10_20d.htm
EX-10.19D - EXHIBIT 10.19D - Regen BioPharma Incex10_19d.htm
EX-10.18D - EXHIBIT 10.18D - Regen BioPharma Incex10_18d.htm
EX-10.17D - EXHIBIT 10.17D - Regen BioPharma Incex10_17d.htm
EX-10.16D - EXHIBIT 10.16D - Regen BioPharma Incex10_16d.htm
EX-10.15D - EXHIBIT 10.15D - Regen BioPharma Incex10_15d.htm
EX-10.14D - EXHIBIT 10.14D - Regen BioPharma Incex10_14d.htm
EX-10.13D - EXHIBIT 10.13D - Regen BioPharma Incex10_13d.htm
EX-10.12D - EXHIBIT 10.12D - Regen BioPharma Incex10_12d.htm
EX-10.11D - EXHIBIT 10.11D - Regen BioPharma Incex10_11d.htm
EX-10.10D - EXHIBIT 10.10D - Regen BioPharma Incex10_10d.htm
EX-10.9D - EXHIBIT 10.9D - Regen BioPharma Incex10_9d.htm
EX-10.8D - EXHIBIT 10.8D - Regen BioPharma Incex10_8d.htm
EX-10.7F - EXHIBIT 10.7F - Regen BioPharma Incex10_7f.htm
EX-10.7D - EXHIBIT 10.7D - Regen BioPharma Incex10_7d.htm
EX-10.6F - EXHIBIT 10.6F - Regen BioPharma Incex10_6f.htm
EX-10.6D - EXHIBIT 10.6D - Regen BioPharma Incex10_6d.htm
EX-10.5F - EXHIBIT 10.5F - Regen BioPharma Incex10_5f.htm
EX-10.5D - EXHIBIT 10.5D - Regen BioPharma Incex10_5d.htm
EX-10.4E - EXHIBIT 10.4E - Regen BioPharma Incex10_4e.htm
EX-10.4D - EXHIBIT 10.4D - Regen BioPharma Incex10_4d.htm
EX-10.3E - EXHIBIT 10.3E - Regen BioPharma Incex10_3e.htm
EX-10.3D - EXHIBIT 10.3D - Regen BioPharma Incex10_3d.htm
EX-10.2E - EXHIBIT 10.2E - Regen BioPharma Incex10_2e.htm
EX-10.1G - EXHIBIT 10.1G - Regen BioPharma Incex10_1g.htm
EX-10.1D - EXHIBIT 10.1D - Regen BioPharma Incex10_1d.htm

 

AGREEMENT BY AND BETWEEN REGEN BIOPHARMA, INC. AND ZANDER THERAPEUTICS, INC.

Dated December 15, 2017

 

WHEREAS, REGEN BIOPHARMA, INC. (“REGEN”) AND ZANDER THERAPEUTICS, INC. (“ZANDER”) ARE PARTIES TO THAT AGREEMENT DATED JUNE 23, 2015 WITH ZANDER WHEREBY REGEN GRANTED TO ZANDER AN EXCLUSIVE WORLDWIDE RIGHT AND LICENSE FOR THE DEVELOPMENT AND COMMERCIALIZATION OF ANY AND ALL INTELLECTUAL PROPERTY CONTROLLED BY REGEN (“LICENSE AGREEMENT”).

WHEREAS IT HAS BEEN DETERMINED THAT ZANDER HAS NO DESIRE TO DEVELOP AND COMMERCIALIZE CERTAIN INTELLECTUAL PROPERTY CONTROLLED BY REGEN.

THEREFORE IT IS AGREED AS FOLLOWS:

EXHIBIT A OF THE LICENSE AGREEMENT SHALL BE AND READ:

Exhibit A

Any and all intellectual property controlled by Regen Biopharma, Inc. exclusive of trademarks and also exclusive of (a)that intellectual property for which a license has been granted to Regen Biopharma, Inc. by Benitec Australia Limited on August 5, 2013, (b) US Patent #8389708, and (c) US Patent #8263571

 

EACH PARTY HEREBY IS DULY ORGANIZED, VALIDLY EXISTING AND IN GOOD STANDING UNDER THE LAWS OF THEIR RESPECTIVE JURISDICTION. EACH PARTY HAS THE FULL RIGHT AND POWER TO ENTER INTO AND PERFORM ITS OBLIGATIONS UNDER THIS AGREEMENT AND EACH HAS DULY AUTHORIZED, EXECUTED AND DELIVERED THIS AGREEMENT WHICH IS BINDING UPON, AND ENFORCEABLE AGAINST, EACH PARTY IN ACCORDANCE WITH ITS TERMS. TO THE BEST KNOWLEDGE OF EACH PARTY THERE IS NO ACTION AT LAW OR IN EQUITY, NO ARBITRATION PROCEEDING AND NO ACTION, PROCEEDING, COMPLAINT OR INVESTIGATION BEFORE OR BY ANY FEDERAL, FOREIGN, STATE OR LOCAL GOVERNMENT OR REGULATORY COMMISSION, AGENCY OR OTHER ADMINISTRATIVE OR REGULATORY BODY OR AUTHORITY PENDING OR THREATENED AGAINST OR AFFECTING EITHER PARTY ITS OFFICERS, DIRECTORS, BUSINESS OR AFFAIRS THAT WILL AFFECT THE SET OVER OF THE ASSIGNED PATENT AND THE EQUITABLE CONSIDERATION, AS STATED HEREIN.

ALL QUESTIONS CONCERNING THE CONSTRUCTION, VALIDITY, ENFORCEMENT AND INTERPRETATION OF THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE INTERNAL LAWS OF THE STATE OF CALIFORNIA, WITHOUT REGARD TO THE PRINCIPLES OF CONFLICTS OF LAW THEREOF. EACH PARTY HEREBY IRREVOCABLY SUBMITS TO THE EXCLUSIVE JURISDICTION OF THE STATE AND FEDERAL COURTS SITTING IN CALIFORNIA FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR WITH ANY TRANSACTION CONTEMPLATED HEREBY OR DISCUSSED HEREIN AND HEREBY IRREVOCABLY WAIVES, AND AGREES NOT TO ASSERT IN ANY SUIT, ACTION OR PROCEEDING, ANY CLAIM THAT IT IS NOT PERSONALLY SUBJECT TO THE JURISDICTION OF ANY SUCH COURT, THAT SUCH SUIT, ACTION OR PROCEEDING IS IMPROPER OR INCONVENIENT VENUE FOR SUCH PROCEEDING. IF EITHER PARTY SHALL COMMENCE AN ACTION OR PROCEEDING TO ENFORCE ANY PROVISIONS OF THIS AGREEMENT, THEN THE PREVAILING PARTY IN SUCH ACTION 

OR PROCEEDING SHALL BE REIMBURSED BY THE OTHER PARTY FOR ITS ATTORNEYS’ FEES AND OTHER COSTS AND EXPENSES INCURRED WITH THE INVESTIGATION, PREPARATION AND PROSECUTION OF SUCH ACTION OR PROCEEDING.

ALL QUESTIONS CONCERNING THE CONSTRUCTION, VALIDITY, ENFORCEMENT AND INTERPRETATION OF THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE INTERNAL LAWS OF THE STATE OF CALIFORNIA, WITHOUT REGARD TO THE PRINCIPLES OF CONFLICTS OF LAW THEREOF. EACH PARTY HEREBY IRREVOCABLY SUBMITS TO THE EXCLUSIVE JURISDICTION OF THE STATE AND FEDERAL COURTS SITTING IN CALIFORNIA FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR WITH ANY TRANSACTION CONTEMPLATED HEREBY OR DISCUSSED HEREIN AND HEREBY IRREVOCABLY WAIVES, AND AGREES NOT TO ASSERT IN ANY SUIT, ACTION OR PROCEEDING, ANY CLAIM THAT IT IS NOT PERSONALLY SUBJECT TO THE JURISDICTION OF ANY SUCH COURT, THAT SUCH SUIT, ACTION OR PROCEEDING IS IMPROPER OR INCONVENIENT VENUE FOR SUCH PROCEEDING. IF EITHER PARTY SHALL COMMENCE AN ACTION OR PROCEEDING TO ENFORCE ANY PROVISIONS OF THIS AGREEMENT, THEN THE PREVAILING PARTY IN SUCH ACTION OR PROCEEDING SHALL BE REIMBURSED BY THE OTHER PARTY FOR ITS ATTORNEYS’ FEES AND OTHER COSTS AND EXPENSES INCURRED WITH THE INVESTIGATION, PREPARATION AND PROSECUTION OF SUCH ACTION OR PROCEEDING.

 

REGEN BIOPHARMA INC.  ZANDER THERAPEUTICS INC.
   
By: /s/David R. Koos By: /s/David R Koos
   
David R. Koos David R. Koos 
Chairman & CEO  Chairman & CEO